TCI Wealth Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-138
Closed -$26K 1388
2023
Q1
$26K Hold
138
﹤0.01% 613
2022
Q4
$29.3K Hold
138
﹤0.01% 549
2022
Q3
$22K Buy
138
+2
+1% +$319 ﹤0.01% 616
2022
Q2
$20K Buy
136
+43
+46% +$6.22K ﹤0.01% 642
2022
Q1
$16K Sell
93
-43
-32% -$7.09K ﹤0.01% 800
2021
Q4
$30K Hold
136
﹤0.01% 541
2021
Q3
$26K Buy
136
+14
+11% +$2.55K ﹤0.01% 586
2021
Q2
$22K Buy
122
+32
+36% +$5.52K ﹤0.01% 590
2021
Q1
$15K Buy
90
+50
+125% +$7.65K 0.01% 657
2020
Q4
$6K Buy
40
+6
+18% +$756 ﹤0.01% 813
2020
Q3
$4K Hold
34
﹤0.01% 860
2020
Q2
$3K Hold
34
﹤0.01% 923
2020
Q1
$2K Buy
+34
New +$2.95K ﹤0.01% 1037
2019
Q4
Sell
-8
Closed -$1K 1632
2019
Q3
$1K Buy
+8
New +$604 ﹤0.01% 1333

Other funds holding MEDP

TCI Wealth Advisors's MEDP Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Medpace (MEDP) in Q2 2023, closing a stake of 138 shares — an estimated $26K sold.

TCI Wealth Advisors first reported a position in MEDP in Q3 2019 and held it in 14 quarters. The position peaked at $30K in Q4 2021. 464 funds tracked by Wall St. Rank hold MEDP as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Medpace position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 138 Medpace shares in Q2 2023, an estimated $26K.
  • TCI Wealth Advisors first reported a position in Medpace in Q3 2019 and held it in 14 quarters.
  • TCI Wealth Advisors's Medpace position peaked at $30K in Q4 2021.
  • 464 funds tracked by Wall St. Rank held Medpace as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.